Effects of Highly Absorptive Curcumin on Inflammation in Chronic Obstructive Pulmonary Disease (HS-Cur COPD study)
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Curcumin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Biomarker; Pharmacodynamics
- Acronyms HS-Cur-COPD
- 24 Apr 2017 Status changed from active, no longer recruiting to completed.
- 20 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 12 Nov 2012 New trial record